Phase II study of PHA-848125AC as second line-treatment in pemetrexed pre-treated malignant pleural mesothelioma patients.
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2012
At a glance
- Drugs Milciclib (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- 11 Jul 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 01 Aug 2011 New trial record